Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from COPD

Is Sylvester Stallone Dead? Not The Actor But The Funk Frontman Sly Stone: Cause Of Death And What We Know

Sly Stone, funk legend and frontman of Sly and the Family Stone, died at 82 from COPD complications. Actor Sylvester Stallone is alive despite online confusion.

International Business Times UK

“A monumental figure, a groundbreaking innovator, and a true pioneer who redefined the landscape of pop, funk, and rock music”: Sly Stone, restlessly creative musical giant who led Sly and the Family Stone, dies at 82

The visionary multi-instrumentalist, singer, and songwriter had been battling COPD, according to his family

Guitar World

Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure

Regeneron stock crashed Friday after the company's Sanofi-partnered COPD treatment unexpectedly failed in a Phase 3 study.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Tuesday's Stock Of The Day is testing a buy point after Verona Pharma broke out last week on blowout sales for its COPD treatment.

Investors Business Daily

Lung disease test done by AI to be rolled out in GP surgeries

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The Independent UK

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The device, known as N-Tidal Diagnose, uses carbon dioxide sensors to measure changes in a patient’s lung function with results given in minutes.

Evening Standard

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

David Lynch death: What are the symptoms and causes of emphysema?

The biggest risk is smoking

The Independent UK

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Investors Business Daily

UK Using AI To Cut Patient Hospital Visits

The government in the United Kingdom is using artificial intelligence (AI) in the healthcare industry to cut down on hospital visits, having already seen a 40% reduction in the number of COPD patients.

International Business Times

First new treatment for asthma and COPD in half a century – new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

The Conversation

New Treatment For Asthma, COPD Flare-Ups: Single Dose Of Existing Antibody Injection May Cut Hospitalizations

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

Medical Daily

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'

The injection is the first new treatment for asthma and COPD attacks in 50 years

Evening Standard

Benralizumab: London scientists create 'game-changing' first treatment for asthma attacks in 50 years

Researchers say injection will be ‘game changing’ for people with the respiratory condition

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

The Independent UK

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells

Evening Standard

First treatment in 50 years for serious asthma attacks is ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

Medical Daily

Study Finds Daily Dose Of Vitamin B3 Reduces Inflammation In COPD Patients

The study suggests that taking vitamin B3 could reduce lung inflammatory biomarkers by up to 63%.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

What is COPD and what are the symptoms?

Every winter, GP surgeries and hospitals see an increase in visits from people with respiratory conditions.

Evening Standard

AI urine analysis predicts infection in lung disease patients a week in advance

The technology could help personalise treatment and prevent hospitalisations, academics said.

Dynamite News

Delhi Poor Air Quality records spike Asthma and COPD cases: AIIMS

AIIMS has reported a increase in cases related to respiratory issues, particularly asthma and COPD allegedly due to Delhi air pollution. Read further on Dynamite News:

The Guardian - UK

Pollutionwatch: Study reveals indoor pollution’s impact on people with COPD

Researchers find pollution in inside spaces – mainly from gas cooking – had greatest effect on those with the disease

Medical Daily

Best Nebulizers For Your Respiratory Health: Here's How To Use Them Effectively

Nebulizers are simple devices designed to deliver medications to the lungs directly, making them crucial for treating everything from common colds to more serious conditions like asthma and chronic obstructive pulmonary disease (COPD). In this guide, we explore the various types of nebulizers, their unique benefits, and practical tips for…

Investors Business Daily

Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent

Regeneron stock rose Friday after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.

Evening Standard

What is emphysema? David Lynch reveals he has lung condition

The Twin Peaks creator, 78, says he developed the condition after years of smoking but quit two years ago

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.